Lisondra, Novelyn .
HRN: 22-13-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/20/2023
11/27/2023
IV
1000mg
Q8H
Sepsis
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes